Eli Lilly profit beats estimates on demand for cancer, diabetes drugs
Eli Lilly profit beats estimates on demand for cancer, diabetes drugs By Reuters Staff 2 Min Read (Reuters) -Eli Lilly and Co beat Wall Street estimates for fourth-quarter profit on Friday, boosted by strong demand for its diabetes and cancer drugs and a partial lift from sales of its COVID-19 antibody treatment. Slideshow ( 2 […]
Read More